135 related articles for article (PubMed ID: 16261276)
1. Simplified pulmonary vasodilatory testing in the cardiac catheterization laboratory with nasal cannula nitric oxide.
Scheurer M; Bandisode V; Atz AM
Pediatr Cardiol; 2006; 27(1):84-86. PubMed ID: 16261276
[TBL] [Abstract][Full Text] [Related]
2. Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing.
Atz AM; Adatia I; Lock JE; Wessel DL
J Am Coll Cardiol; 1999 Mar; 33(3):813-9. PubMed ID: 10080486
[TBL] [Abstract][Full Text] [Related]
3. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.
Ziegler JW; Ivy DD; Wiggins JW; Kinsella JP; Clarke WR; Abman SH
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1388-95. PubMed ID: 9817684
[TBL] [Abstract][Full Text] [Related]
4. Acute hemodynamic effects of pulsed delivery of low flow nasal nitric oxide in children with pulmonary hypertension.
Ivy DD; Griebel JL; Kinsella JP; Abman SH
J Pediatr; 1998 Sep; 133(3):453-6. PubMed ID: 9738734
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide in the evaluation of congenital heart disease with pulmonary hypertension: factors related to nitric oxide response.
Cannon BC; Feltes TF; Fraley JK; Grifka RG; Riddle EM; Kovalchin JP
Pediatr Cardiol; 2005; 26(5):565-9. PubMed ID: 16132310
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of inhaled nitric oxide using pulse delivery and continuous delivery systems in pulmonary hypertension.
Kitamukai O; Sakuma M; Takahashi T; Nawata J; Ikeda J; Shirato K
Intern Med; 2002 Jun; 41(6):429-34. PubMed ID: 12135173
[TBL] [Abstract][Full Text] [Related]
7. Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology.
Krasuski RA; Warner JJ; Wang A; Harrison JK; Tapson VF; Bashore TM
J Am Coll Cardiol; 2000 Dec; 36(7):2204-11. PubMed ID: 11127462
[TBL] [Abstract][Full Text] [Related]
8. The effect of inhaled nitric oxide on the pulmonary circulation of the neonatal pig.
Nelin LD; Moshin J; Thomas CJ; Sasidharan P; Dawson CA
Pediatr Res; 1994 Jan; 35(1):20-4. PubMed ID: 8134193
[TBL] [Abstract][Full Text] [Related]
9. [Cardiac catheterization and pulmonary vasoreactivity testing in children with idiopathic pulmonary arterial hypertension].
Zhang C; Li Q; Liu T; Gu H
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):468-72. PubMed ID: 25190170
[TBL] [Abstract][Full Text] [Related]
10. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease.
Limsuwan A; Khosithseth A; Wanichkul S; Khowsathit P
Catheter Cardiovasc Interv; 2009 Jan; 73(1):98-104. PubMed ID: 19089967
[TBL] [Abstract][Full Text] [Related]
11. [Nitric oxide in therapy of pulmonary hypertension after correction of congenital single atrium].
Strauss JM; Paul T; Krohn S; Sümpelmann R; Hartmann H; Schröder D; Feickert HJ
Anaesthesiol Reanim; 1995; 20(6):162-5. PubMed ID: 8652042
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension.
Hajian B; De Backer J; Vos W; Van Holsbeke C; Ferreira F; Quinn DA; Hufkens A; Claes R; De Backer W
Int J Chron Obstruct Pulmon Dis; 2016; 11():1533-41. PubMed ID: 27462149
[TBL] [Abstract][Full Text] [Related]
13. Preoperative and postoperative response to inhaled nitric oxide.
Turanlahti MI; Laitinen PO; Pesonen EJ
Scand Cardiovasc J; 2000; 34(1):46-52. PubMed ID: 10816060
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Adverse Events in Children with Pulmonary Hypertension Undergoing Cardiac Catheterization.
Vaiyani D; Kelleman M; Downey LA; Kanaan U; Petit CJ; Bauser-Heaton H
Pediatr Cardiol; 2021 Apr; 42(4):736-742. PubMed ID: 33512547
[TBL] [Abstract][Full Text] [Related]
15. [Inhaled nitric oxide (NO) for vasoreactivity testing in pulmonary hypertension].
Burakowski J; Kurzyna M; Fijałkowska A; Kuca P; Szturmowicz M; Torbicki A
Pol Arch Med Wewn; 2004 Apr; 111(4):443-8. PubMed ID: 15517758
[TBL] [Abstract][Full Text] [Related]
16. Selective and sustained pulmonary vasodilation with inhalational nitric oxide therapy in a child with idiopathic pulmonary hypertension.
Kinsella JP; Toews WH; Henry D; Abman SH
J Pediatr; 1993 May; 122(5 Pt 1):803-6. PubMed ID: 8496766
[TBL] [Abstract][Full Text] [Related]
17. Acute vasodilator test in pulmonary arterial hypertension: evaluation of two response criteria.
Costa EL; Jardim C; Bogossian HB; Amato MB; Carvalho CR; Souza R
Vascul Pharmacol; 2005 Sep; 43(3):143-7. PubMed ID: 16061423
[TBL] [Abstract][Full Text] [Related]
18. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests.
Channick RN; Newhart JW; Johnson FW; Williams PJ; Auger WR; Fedullo PF; Moser KM
Chest; 1996 Jun; 109(6):1545-9. PubMed ID: 8769509
[TBL] [Abstract][Full Text] [Related]
19. Vasodilator testing with nitric oxide and/or oxygen in pediatric pulmonary hypertension.
Barst RJ; Agnoletti G; Fraisse A; Baldassarre J; Wessel DL;
Pediatr Cardiol; 2010 Jul; 31(5):598-606. PubMed ID: 20405117
[TBL] [Abstract][Full Text] [Related]
20. CMR fluoroscopy right heart catheterization for cardiac output and pulmonary vascular resistance: results in 102 patients.
Rogers T; Ratnayaka K; Khan JM; Stine A; Schenke WH; Grant LP; Mazal JR; Grant EK; Campbell-Washburn A; Hansen MS; Ramasawmy R; Herzka DA; Xue H; Kellman P; Faranesh AZ; Lederman RJ
J Cardiovasc Magn Reson; 2017 Jul; 19(1):54. PubMed ID: 28750642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
